Global Neurorehabilitation Devices Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Neurorehabilitation Devices Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

According to APO Research, The global Neurorehabilitation Devices market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Neurorehabilitation Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Neurorehabilitation Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Neurorehabilitation Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Neurorehabilitation Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Neurorehabilitation Devices include Medtronic, Abbott Laboratories, Boston Scientific, Bioness, Hocoma AG, Neuronetics, Yiruide, Magstim and VISHEE, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Neurorehabilitation Devices, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Neurorehabilitation Devices, also provides the value of main regions and countries. Of the upcoming market potential for Neurorehabilitation Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neurorehabilitation Devices revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Neurorehabilitation Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Neurorehabilitation Devices company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Neurorehabilitation Devices segment by Company

Medtronic
Abbott Laboratories
Boston Scientific
Bioness
Hocoma AG
Neuronetics
Yiruide
Magstim
VISHEE
Ekso Bionics
Alter G
MagVenture
Tyromotion
Soterix Medical
Neuroelectrics
Bionik Laboratories
Helius Medical
Neurorehabilitation Devices segment by Type

Implantable Neurorehabilitation System
Neurorobotic System
Brain Computer Interface
Non-invasive Stimulators
Other
Neurorehabilitation Devices segment by Application

Hospitals
Clinics
Other
Neurorehabilitation Devices segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Neurorehabilitation Devices status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Neurorehabilitation Devices key companies, revenue, market share, and recent developments.
3. To split the Neurorehabilitation Devices breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Neurorehabilitation Devices market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Neurorehabilitation Devices significant trends, drivers, influence factors in global and regions.
6. To analyze Neurorehabilitation Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurorehabilitation Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurorehabilitation Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurorehabilitation Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neurorehabilitation Devices industry.
Chapter 3: Detailed analysis of Neurorehabilitation Devices company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Neurorehabilitation Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Neurorehabilitation Devices in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Neurorehabilitation Devices Market Size, 2019 VS 2023 VS 2030
1.3 Global Neurorehabilitation Devices Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Neurorehabilitation Devices Market Dynamics
2.1 Neurorehabilitation Devices Industry Trends
2.2 Neurorehabilitation Devices Industry Drivers
2.3 Neurorehabilitation Devices Industry Opportunities and Challenges
2.4 Neurorehabilitation Devices Industry Restraints
3 Neurorehabilitation Devices Market by Company
3.1 Global Neurorehabilitation Devices Company Revenue Ranking in 2023
3.2 Global Neurorehabilitation Devices Revenue by Company (2019-2024)
3.3 Global Neurorehabilitation Devices Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Neurorehabilitation Devices Company Manufacturing Base & Headquarters
3.5 Global Neurorehabilitation Devices Company, Product Type & Application
3.6 Global Neurorehabilitation Devices Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Neurorehabilitation Devices Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Neurorehabilitation Devices Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 Neurorehabilitation Devices Market by Type
4.1 Neurorehabilitation Devices Type Introduction
4.1.1 Implantable Neurorehabilitation System
4.1.2 Neurorobotic System
4.1.3 Brain Computer Interface
4.1.4 Non-invasive Stimulators
4.1.5 Other
4.2 Global Neurorehabilitation Devices Sales Value by Type
4.2.1 Global Neurorehabilitation Devices Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Neurorehabilitation Devices Sales Value by Type (2019-2030)
4.2.3 Global Neurorehabilitation Devices Sales Value Share by Type (2019-2030)
5 Neurorehabilitation Devices Market by Application
5.1 Neurorehabilitation Devices Application Introduction
5.1.1 Hospitals
5.1.2 Clinics
5.1.3 Other
5.2 Global Neurorehabilitation Devices Sales Value by Application
5.2.1 Global Neurorehabilitation Devices Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Neurorehabilitation Devices Sales Value by Application (2019-2030)
5.2.3 Global Neurorehabilitation Devices Sales Value Share by Application (2019-2030)
6 Neurorehabilitation Devices Market by Region
6.1 Global Neurorehabilitation Devices Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Neurorehabilitation Devices Sales Value by Region (2019-2030)
6.2.1 Global Neurorehabilitation Devices Sales Value by Region: 2019-2024
6.2.2 Global Neurorehabilitation Devices Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Neurorehabilitation Devices Sales Value (2019-2030)
6.3.2 North America Neurorehabilitation Devices Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Neurorehabilitation Devices Sales Value (2019-2030)
6.4.2 Europe Neurorehabilitation Devices Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Neurorehabilitation Devices Sales Value (2019-2030)
6.5.2 Asia-Pacific Neurorehabilitation Devices Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Neurorehabilitation Devices Sales Value (2019-2030)
6.6.2 Latin America Neurorehabilitation Devices Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Neurorehabilitation Devices Sales Value (2019-2030)
6.7.2 Middle East & Africa Neurorehabilitation Devices Sales Value Share by Country, 2023 VS 2030
7 Neurorehabilitation Devices Market by Country
7.1 Global Neurorehabilitation Devices Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Neurorehabilitation Devices Sales Value by Country (2019-2030)
7.2.1 Global Neurorehabilitation Devices Sales Value by Country (2019-2024)
7.2.2 Global Neurorehabilitation Devices Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.3.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.4.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.5.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.6.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.7.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.8.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.9.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.10.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.11.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.12.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.13.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.14.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.15.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.16.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.17.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.18.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.19.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.20.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Neurorehabilitation Devices Sales Value Growth Rate (2019-2030)
7.21.2 Global Neurorehabilitation Devices Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Neurorehabilitation Devices Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 Medtronic
8.1.1 Medtronic Comapny Information
8.1.2 Medtronic Business Overview
8.1.3 Medtronic Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
8.1.4 Medtronic Neurorehabilitation Devices Product Portfolio
8.1.5 Medtronic Recent Developments
8.2 Abbott Laboratories
8.2.1 Abbott Laboratories Comapny Information
8.2.2 Abbott Laboratories Business Overview
8.2.3 Abbott Laboratories Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
8.2.4 Abbott Laboratories Neurorehabilitation Devices Product Portfolio
8.2.5 Abbott Laboratories Recent Developments
8.3 Boston Scientific
8.3.1 Boston Scientific Comapny Information
8.3.2 Boston Scientific Business Overview
8.3.3 Boston Scientific Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
8.3.4 Boston Scientific Neurorehabilitation Devices Product Portfolio
8.3.5 Boston Scientific Recent Developments
8.4 Bioness
8.4.1 Bioness Comapny Information
8.4.2 Bioness Business Overview
8.4.3 Bioness Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
8.4.4 Bioness Neurorehabilitation Devices Product Portfolio
8.4.5 Bioness Recent Developments
8.5 Hocoma AG
8.5.1 Hocoma AG Comapny Information
8.5.2 Hocoma AG Business Overview
8.5.3 Hocoma AG Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
8.5.4 Hocoma AG Neurorehabilitation Devices Product Portfolio
8.5.5 Hocoma AG Recent Developments
8.6 Neuronetics
8.6.1 Neuronetics Comapny Information
8.6.2 Neuronetics Business Overview
8.6.3 Neuronetics Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
8.6.4 Neuronetics Neurorehabilitation Devices Product Portfolio
8.6.5 Neuronetics Recent Developments
8.7 Yiruide
8.7.1 Yiruide Comapny Information
8.7.2 Yiruide Business Overview
8.7.3 Yiruide Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
8.7.4 Yiruide Neurorehabilitation Devices Product Portfolio
8.7.5 Yiruide Recent Developments
8.8 Magstim
8.8.1 Magstim Comapny Information
8.8.2 Magstim Business Overview
8.8.3 Magstim Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
8.8.4 Magstim Neurorehabilitation Devices Product Portfolio
8.8.5 Magstim Recent Developments
8.9 VISHEE
8.9.1 VISHEE Comapny Information
8.9.2 VISHEE Business Overview
8.9.3 VISHEE Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
8.9.4 VISHEE Neurorehabilitation Devices Product Portfolio
8.9.5 VISHEE Recent Developments
8.10 Ekso Bionics
8.10.1 Ekso Bionics Comapny Information
8.10.2 Ekso Bionics Business Overview
8.10.3 Ekso Bionics Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
8.10.4 Ekso Bionics Neurorehabilitation Devices Product Portfolio
8.10.5 Ekso Bionics Recent Developments
8.11 Alter G
8.11.1 Alter G Comapny Information
8.11.2 Alter G Business Overview
8.11.3 Alter G Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
8.11.4 Alter G Neurorehabilitation Devices Product Portfolio
8.11.5 Alter G Recent Developments
8.12 MagVenture
8.12.1 MagVenture Comapny Information
8.12.2 MagVenture Business Overview
8.12.3 MagVenture Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
8.12.4 MagVenture Neurorehabilitation Devices Product Portfolio
8.12.5 MagVenture Recent Developments
8.13 Tyromotion
8.13.1 Tyromotion Comapny Information
8.13.2 Tyromotion Business Overview
8.13.3 Tyromotion Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
8.13.4 Tyromotion Neurorehabilitation Devices Product Portfolio
8.13.5 Tyromotion Recent Developments
8.14 Soterix Medical
8.14.1 Soterix Medical Comapny Information
8.14.2 Soterix Medical Business Overview
8.14.3 Soterix Medical Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
8.14.4 Soterix Medical Neurorehabilitation Devices Product Portfolio
8.14.5 Soterix Medical Recent Developments
8.15 Neuroelectrics
8.15.1 Neuroelectrics Comapny Information
8.15.2 Neuroelectrics Business Overview
8.15.3 Neuroelectrics Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
8.15.4 Neuroelectrics Neurorehabilitation Devices Product Portfolio
8.15.5 Neuroelectrics Recent Developments
8.16 Bionik Laboratories
8.16.1 Bionik Laboratories Comapny Information
8.16.2 Bionik Laboratories Business Overview
8.16.3 Bionik Laboratories Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
8.16.4 Bionik Laboratories Neurorehabilitation Devices Product Portfolio
8.16.5 Bionik Laboratories Recent Developments
8.17 Helius Medical
8.17.1 Helius Medical Comapny Information
8.17.2 Helius Medical Business Overview
8.17.3 Helius Medical Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
8.17.4 Helius Medical Neurorehabilitation Devices Product Portfolio
8.17.5 Helius Medical Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings